Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLICLAZIDE for Cardiovascular event prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where GLICLAZIDE was used for Cardiovascular event prophylaxis.

Most Reported Side Effects for GLICLAZIDE

Side Effect Reports % Deaths Hosp.
Hypoglycaemia 756 13.1% 67 483
Nausea 596 10.3% 16 355
Acute kidney injury 553 9.6% 57 348
Drug ineffective 507 8.8% 3 206
Fall 415 7.2% 6 347
Dyspnoea 400 6.9% 50 266
Vomiting 385 6.7% 9 293
Lactic acidosis 373 6.5% 91 142
Malaise 360 6.2% 9 263
Hypertension 351 6.1% 1 158
Fatigue 338 5.8% 0 254
Diarrhoea 337 5.8% 16 160
Cough 335 5.8% 0 204
Diabetes mellitus inadequate control 332 5.7% 0 136
Headache 328 5.7% 1 241

Other Indications for GLICLAZIDE

Type 2 diabetes mellitus (1,859) Product used for unknown indication (1,832) Diabetes mellitus (1,414) Blood pressure measurement (107) Blood pressure abnormal (48) Insulin-requiring type 2 diabetes mellitus (48) Blood glucose increased (39) Hyperglycaemia (29) Type 1 diabetes mellitus (24) Poisoning deliberate (19)

Other Drugs Used for Cardiovascular event prophylaxis

ATORVASTATIN (4,792) LIPITOR (1,863) ASPIRIN (950) ASPIRIN DL-LYSINE (653) CANAKINUMAB (560) RIVAROXABAN (432) CLOPIDOGREL BISULFATE (414) TICAGRELOR (351) SEMAGLUTIDE (207) ICOSAPENT ETHYL (196)

Related Pages

GLICLAZIDE Full Profile All Cardiovascular event prophylaxis Drugs GLICLAZIDE Demographics GLICLAZIDE Timeline